Skin Diseases: Clinical Trials

1,510 trials for Skin Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

857 completed, 239 unknown, 126 recruiting, 110 terminated. 1510 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41510Completed 857, Unknown 239, Recruiting 126, Terminated 110, Not yet recruiting 76, Withdrawn 58, Active not recruiting 33, Enrolling by invitation 11

Follow Skin Diseases: new trials by email Literature Review of Skin Diseases trials Research Report on Skin Diseases

Trials (filtered) newest first · largest first

All 1,510 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
Skin Cleanser Combination No.1 - Atopic Dermatitis
Phase 4Not yet recruitingBoston Children's Hospital1002031-01-012026-03-10
Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery
Suzetrigine, Acetaminophen Plus Ibuprofen - Postoperative Pain, Acute Pain
Phase 4Not yet recruitingUniversity of Minnesota2302027-04-012026-09-25
Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant Setting
Phytotherapy Dietary Supplement (Harpagophytum, Meadowsweet, and Blackcurrant), Patient Experience Questionnaire - Hormone Therapy-induced Arthralgia, Phytotherapy
Phase 4Not yet recruitingHospices Civils de Lyon1052027-01-012026-11-03
Opzelura Experience Study
ruxolitinib, ruxolitinib and an Eczema Action Plan - Atopic Dermatitis
Phase 4Not yet recruitingWake Forest University Health Sciences502026-12-012026-09-04
Comparative Efficacy of Luliconazole and Bifonazole Combined With Itraconazole in Dermatophytosis
Itraconazole, Luliconazole Cream 1%, Bifonazole cream 1% - Tinea Corporis, Tinea Cruris
Phase 4Not yet recruitingUniversity of Faisalabad1822026-12-012026-11-12
A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Unresectable or Metastatic Melanoma Participants In India
Nivolumab + Relatlimab - Unresectable Melanoma, Metastatic Melanoma
Phase 4Not yet recruitingBristol-Myers Squibb402026-11-152026-08-12
AD Treatment Optimization With Ebglyss in Real-World Practice: A Multicenter Study of Patient-Centered Outcomes
Lebrikizumab-lbkz - Atopic Dermatitis
Phase 4Not yet recruitingForefront Dermatology S.C2502026-11-112026-10-02
Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma
Tranexamic acid, Standardised sunscreen and emollient - Melasma
Phase 4Not yet recruitingAllied Hospital Faisalabad1282026-11-012026-10-19
Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne
Clascoterone 1% cream, Clindamycin 1% lotion, Adapalene 0.1%/benzoyl peroxide 2.5% gel - Acne Vulgaris
Phase 4Not yet recruitingAllied Hospital Faisalabad1182026-11-012026-10-19
Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds
Non-conforming pz-cel surgical application to RDEB wounds, Additional biopsies, Pz-cel surgical application to DEB wounds - Epidermolysis Bullosa (EB), Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Phase 4Not yet recruitingAbeona Therapeutics, Inc1002026-11-012026-08-06
Emerging Indications for Hyperbaric Oxygen Treatment
Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis
Phase 4Not yet recruitingJay C. Buckey Jr.1002026-11-012026-09-09
FES PET/MRI for Occult Disease in Lobular Breast Cancer
18Fluoroestradiol (18F-FES), MRI, Gadolinium-based contrast agent (GBCA) - Lobular Breast Carcinoma
Phase 4RecruitingUniversity of Wisconsin, Madison302026-11-012026-11-10
A Study to Investigate Dupixent/ Dupilumab in Adult Indian Participants With Moderate-to-severe Atopic Dermatitis
Dupilumab - Atopic Dermatitis
Phase 4Not yet recruitingSanofi562026-10-282026-10-29
Clinical Evaluation of an Oil-Balancing Facial Sunscreen With Topical Tretinoin
oil-balancing sunscreen - Acne
Phase 4Enrolling by invitationColgate Palmolive402026-10-282026-11-12
Microneedling-Assisted Metformin, Tranexamic Acid, and Modified Kligman's Formula for Melasma
Metformin 30% Topical Lotion, Tranexamic Acid 0.5% Topical Solution, Modified Kligman's Formula - Melasma (Facial Melasma)
Phase 4Enrolling by invitationSameh Sarsik802026-10-252026-10-27
Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia
Lower-Extremity Revascularization, Donaperminogene Seltoplasmid - Chronic Limb-Threatening Ischemia, Diabetic Foot Ulcer
Phase 4Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical University1802026-10-202026-09-18
Efficacy and Safety of Triple-Combination Cream Plus Microneedling Along With Tranexamic Acid Versus Platelet-Rich Plasma in the Treatment of Moderate-to-Severe Melasma: A Randomized Comparative Study
Group B (Triple Combination Cream + Microneedling + Platelet-Rich Plasma) - Melasma (Facial Melasma)
Phase 4Active not recruitingBangladesh Medical University602026-10-132026-10-23
Bimzelx (Bimekizumab) For The Treatment Of Adult Onset Pityriasis Rubra Pilaris (PRP)
Bimekizumab - Pityriasis Rubra Pilaris
Phase 4Not yet recruitingMayo Clinic122026-10-012026-09-08
A Study of QL1706 Combined With OH2 Injection in Perioperative Treatment of Stage III Resectable Acral Melanoma
Iparomlimab and Tuvonralimab Injection (QL1706), OH2 Injection(Recombinant Human GM-CSF Oncolytic Type II Herpes Simplex Virus) - Melanoma, Acral Melanoma
Phase 4Not yet recruitingPeking University Cancer Hospital & Institute762026-10-012026-10-02
Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail
Itraconazole (200 mg), ISOtretinoin 20 MG - Tinea Corporis
Phase 4Not yet recruitingPak Emirates Military Hospital602026-10-012026-06-30

Showing 20 of 1510. Sign in to see all of them.

Narrower conditions

Breast Neoplasms (280)  ·  Psoriasis (184)  ·  Dermatitis, Atopic (136)  ·  Acne Vulgaris (122)  ·  Diabetic Foot (55)  ·  Arthritis, Psoriatic (48)  ·  Keratosis, Actinic (46)  ·  Pruritus (33)  ·  Eczema (29)  ·  Melanoma (27)  ·  Rosacea (27)  ·  Melanosis (26)  ·  Alopecia Areata (25)  ·  HIV Infections (24)

Broader conditions

Skin and Connective Tissue Diseases (1509)  ·  Neoplasms (376)  ·  Neoplasms by Site (325)  ·  Breast Diseases (289)  ·  Immune System Diseases (281)  ·  Skin Diseases, Papulosquamous (250)  ·  Pathological Conditions, Signs and Symptoms (240)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (188)  ·  Hypersensitivity (187)  ·  Genetic Diseases, Inborn (178)  ·  Hypersensitivity, Immediate (177)  ·  Cardiovascular Diseases (167)  ·  Dermatitis (166)  ·  Skin Diseases, Eczematous (165)

Interventions

Methotrexate (32)  ·  Gels (30)  ·  Etanercept (29)  ·  dupilumab (29)  ·  Adalimumab (26)  ·  Adapalene (26)  ·  Benzoyl Peroxide (23)  ·  Standard of Care (23)  ·  Sodium Chloride (22)  ·  apremilast (22)  ·  pimecrolimus (22)  ·  secukinumab (22)  ·  Doxycycline (21)  ·  Triamcinolone Acetonide (21)  ·  Letrozole (20)

Sponsors

Galderma R&D (39)  ·  Novartis Pharmaceuticals (28)  ·  Assiut University (27)  ·  Stiefel, a GSK Company (21)  ·  Ottawa Hospital Research Institute (18)  ·  Cairo University (17)  ·  Novartis (17)  ·  University of California, San Francisco (17)  ·  Hoffmann-La Roche (14)  ·  Allergan (13)  ·  Psoriasis Treatment Center of Central New Jersey (13)  ·  Amgen (12)  ·  Bausch Health Americas, Inc. (12)  ·  Mahidol University (12)  ·  Pfizer (12)

Countries

United States (571)  ·  China (111)  ·  Germany (92)  ·  Canada (85)  ·  France (75)  ·  Spain (65)  ·  United Kingdom (58)  ·  Italy (57)  ·  Egypt (56)  ·  Netherlands (52)  ·  Denmark (42)  ·  Belgium (40)  ·  India (37)  ·  Brazil (35)  ·  South Korea (32)

Top investigators

Ronald W Gottschalk, MD (9)  ·  Robert Bissonnette, MD (8)  ·  Herbert B Slade, MD (7)  ·  Leon H. Kircik, M.D. (6)

Results publications

PMID 38979716, PMID 19935134, PMID 22882561, PMID 25913550, PMID 26982791, PMID 28924971, PMID 29951993, PMID 30415588, PMID 15389191, PMID 20684151, PMID 25071111, PMID 25153486, PMID 26348120, PMID 26438146, PMID 27432417, PMID 28532759, PMID 29448838, PMID 29776990, PMID 30243803, PMID 33283264, PMID 34061144, PMID 42694939, PMID 42825996, PMID 10233295, PMID 1052771, PMID 10536559, PMID 10607349, PMID 10642676, PMID 10865927, PMID 10951254, PMID 11050519, PMID 11063900, PMID 11096382, PMID 11256129, PMID 11453873, PMID 11463434, PMID 11488820, PMID 11855913, PMID 11966728, PMID 12095065, PMID 12127688, PMID 12243706, PMID 12457622, PMID 12533168, PMID 12553848, PMID 12810507, PMID 12839559, PMID 12893742, PMID 13519856, PMID 13571547

NIH funding

2015 (9), 2008 (8), 2018 (8), 2016 (7), 2023 (7), 2004 (5), 2025 (5), 2014 (4), 2019 (4), 2005 (3), 2009 (3), 2017 (2), K23AI070078 (1), K23AR080043 (1), K23DK079789 (1)